Skip to main content
Premium Trial:

Request an Annual Quote

Tina Nova

OpGen has appointed Tina Nova to its board of directors. Nova currently serves as president and CEO of newly formed molecular diagnostics company Molecular Stethoscope, and most recently served as senior vice president and general manager of Illumina's oncology business unit. From 2000 to 2014, Nova was cofounder, director, president, and CEO of Genoptix Medical Laboratory, which was purchased by Novartis for nearly $500,000 in 2011. She has also held senior positions with Nanogen, Ligand Pharmaceuticals, and Hybritech. She currently serves on the board of Arena Pharmaceuticals and Veracyte, and is vice chairman of the board for the newly formed Rady Pediatric Genomics and Systems Medicine Institute.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.